<DOC>
	<DOC>NCT00000331</DOC>
	<brief_summary>The purpose of this study is to assess the abuse liability and examine the reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in healthy, non-drug dependent volunteers.</brief_summary>
	<brief_title>Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6</brief_title>
	<detailed_description>not available at this time</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine, Naloxone Drug Combination</mesh_term>
	<criteria>Individuals must be healthy, nondrug dependent volunteers, be at least 18 years of age, and have no prior history of drug or alcohol abuse or dependence. Subjects must have had some minimal experience with opioids (e.g. at least two prior exposures) Individuals with evidence of an active Diagnostic and Statistical Manual of Mental Disorders (DSMIV) Axis I psychiatric disorder (e.g. psychosis, manicdepressive illness, organic psychiatric disorders), significant medical illness (e.g., liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Heroin Dependence</keyword>
</DOC>